Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AssigneePharmacia Italia S.p.A.
InventorsDaniela Berta, Barbara Forte, Sergio Mantegani, Mario Varasi, Paola Vianello
Life of this patent
Estimating the term…
Abstract
Pyrazolyl-indole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
Claims27
A method for treating diseases caused by and/or associated with an altered protein kinase activity, by administering to a mammal in need thereof an effective amount of a compound of formula (I)
- wherein
- R is hydrogen, halogen, nitro, cyano, hydroxy, or it is a group optionally further substituted selected from straight or branched C1-C6 alkyl or C1-C6 alkoxy, C3-C6 cycloalkyl, aryl, heterocyclyl, or it is a group —NR′R″, —CONR′R″, —NR′COR″, —COOR′ or —SO2NR′R″, wherein R′ and R″ are, the same or different and independently in each occasion, a hydrogen atom or a group optionally further substituted selected from straight or branched C1-C6 alkyl, C3-C6 cycloalkyl, aryl or heterocyclyl;
- or, taken together with the nitrogen atom to which they are attached, R′ and R″ may form a 5 or 6 membered nitrogen containing heterocycle, optionally comprising one additional heteroatom selected among N, O or S;
- R1 has the meanings above reported to r but other than hydroxy;
- m is an integer from 1 to 4;
- n is 1 or 2;
- and the pharmaceutically acceptable salts thereof.
A compound of formula (I)
- wherein
- R is hydrogen, halogen, nitro, cyano, hydroxy, or it is a group optionally further substituted selected from straight or branched C1-C6 alkyl or C1-C6 alkoxy, C3-C6 cycloalkyl, aryl, heterocyclyl, or it is a group —NR′R″, —CONR′R″, —NR′COR″, —COOR′ or
- —SO2NR′R″, wherein R′ and R″ are, the same or different and independently in each occasion, a hydrogen atom or a group optionally further substituted selected from straight or branched C1-C6 alkyl, C3-C6 cycloalkyl, aryl or heterocyclyl;
- or, taken together with the nitrogen atom to which they are attached, R′ and R″ may form a 5 or 6 membered nitrogen containing heterocycle, optionally comprising one additional heteroatom selected among N, O or S;
- R1 has the meanings above reported to R but other than hydroxy;
- m is an integer from 1 to 4;
- n is 1 or 2;
- and the pharmaceutically acceptable salts thereof.
The process of claim 21 wherein, in step (e), the Lewis acid is selected from zinc chloride, boron trifluoride, triethylaluminum or trifluoroacetic anhydride.
A library of two or more compounds of formula (I)
- wherein
- R is hydrogen, halogen, nitro, cyano, hydroxy, or it is a group optionally further substituted selected from straight or branched C1-C6 alkyl or C1-C6 alkoxy, C3-C6 cycloalkyl, aryl, heterocyclyl, or it is a group —NR′R″, —CONR′R″, —NR′COR″, —COOR′ or —SO2NR′R″, wherein R′ and R″ are, the same or different and independently in each occasion, a hydrogen atom or a group optionally further substituted selected from straight or branched C1-C6 alkyl, C3-C6 cycloalkyl, aryl or heterocyclyl;
- or, taken together with the nitrogen atom to which they are attached, R′ and R″ may form a 5 or 6 membered nitrogen containing heterocycle, optionally comprising one additional heteroatom selected among N, O or S;
- R1 has the meanings above reported to R but other than hydroxy;
- m is an integer from 1 to 4;
- n is 1 or 2;
- and the pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.